Understanding breast cancer outcomes in Asian American women
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
This study looks at why Asian American women tend to live longer after being diagnosed with breast cancer compared to other groups, exploring different health habits and immune responses to find out what helps them survive better, with the hope of using these insights to improve care for all breast cancer patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10871850 on NIH RePORTER |
What this research studies
This research investigates why Asian American women have better survival rates from breast cancer compared to other racial and ethnic groups. It examines various factors, including health behaviors, clinical characteristics, and immune responses, to identify protective elements that contribute to this survival advantage. By analyzing data from multiple cohort studies, the research aims to uncover differences among Asian American ethnic groups and how these differences impact breast cancer prognosis. The goal is to provide insights that could improve treatment and outcomes for all breast cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are Asian American women diagnosed with breast cancer.
Not a fit: Patients who do not identify as Asian American or those with other types of cancer may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the identification of protective factors that enhance breast cancer survival, benefiting patients across diverse backgrounds.
How similar studies have performed: Previous research has highlighted the importance of studying diverse populations, suggesting that this approach could yield significant insights into breast cancer outcomes.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Gomez, Scarlett L — University of California, San Francisco
- Study coordinator: Gomez, Scarlett L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.